Alimera Sciences Inc to Discuss NEW DAY Clinical Trial Conference Call Transcript
Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to the Alimera Sciences NEW DAY trial initiation conference call. (Operator Instructions)
Participants of this call are advised that the audio of this conference is being broadcast live over the Internet and is also being recorded for playback purposes. A webcast replay of the call will be available approximately 1 hour after the end of the call through October 15, 2020.
I would now like to turn the call over to Scott Gordon, President of CORE IR, the company's investor relations firm. Please go ahead, sir.
Thank you, Sarah. Good afternoon, and thank you all for joining today's conference call. Joining me from Alimera's leadership team are Rick Eiswirth, President, Chief Executive Officer; and Samer Kaba, Chief Medical Officer.
Participants are advised that a presentation accompanying this conference call is available in the Investors section of the company's website at
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
